Market Overview:
The global thymidine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for thymidine in various applications such as medicine, chemical products, and others. Additionally, the growing population and rising income levels are also contributing to the growth of this market. However, factors such as stringent regulations and high cost of production are restraining the growth of this market.
 Industry Outlook.svg)
Product Definition:
?-Thymidine is a nucleoside that is used in the synthesis of DNA. It is also known as thymine.
Pharmaceutical Grade:
Pharmaceutical grade is a term used for drugs that are manufactured in accordance with good manufacturing practices (GMP) as defined by the U.S. Food and Drug Administration (FDA).
The FDA has established GMP for quality assurance in drug manufacturing, which includes procedures to be followed during product development, production, packaging, storage & shipment of pharmaceutical products.
Industrial Grade:
Industrial grade is a high purity form of thymidine, which is used as an intermediate in the production of pharmaceutical drugs and other chemical products. It has applications in the pharmaceutical industry for tablet molds and as a raw material for drug manufacturing.
Application Insights:
The medicine segment accounted for the largest revenue share of over 50% in 2017. The growth can be attributed to the increasing usage of thymidine derivatives as antineoplastic drugs, which are used in the treatment of various cancers such as breast cancer, lung cancer and bone metastasis. In addition, it is also used for other diseases such as Parkinson¢â‚¬â„¢s disease and leukemia.
Chemical products segment is expected to witness lucrative growth over the forecast period owing to rising demand from various end-use industries including pharmaceuticals and food processing. It is also extensively utilized in chemical synthesis due to its ability to act as a catalyst when exposed to nucleophiles like alcohols and aryl halides that react with each other at room temperature without any need for heating or cooling down.
Regional Analysis:
North America dominated the global market in 2017. The presence of major companies and well-established healthcare infrastructure are some of the factors responsible for its large share. Moreover, increasing R&D activities to develop novel drugs is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by various governments in developing countries such as India and China for improving healthcare facilities & services along with growing demand for medicines due to an aging population and increasing prevalence of chronic diseases such as cancer, diabetes, & cardiovascular disorders among others. These factors are expected contribute towards a significant increase in demand during the forecast period from 2018 to 2030 in this region.
Growth Factors:
- Increasing demand from pharmaceutical and biotechnology industries for use in anticancer drugs
- Growing demand from the medical diagnostics industry for use in nucleic acid sequencing, polymerase chain reaction (PCR), and other diagnostic applications
- Rising prevalence of cancer and other diseases that require thymidine-based therapies
- Increased research funding for thymidine-related drug discovery and development programs
- Technological advances that improve the efficiency of thymidine production or delivery
Scope Of The Report
Report Attributes
Report Details
Report Title
?-Thymidine (CAS 50-89-5) Market Research Report
By Type
Pharmaceutical Grade, Industrial Grade
By Application
Medicine, Chemical Products, Others
By Companies
Stereo Drugs, Zhejiang NHU, Hangzhou Neway Chemicals, Coben Pharmaceutical, Anhui Jintaiyang Pharmaceutical, Wuhan Fortuna Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global ?-Thymidine (CAS 50-89-5) Market Report Segments:
The global ?-Thymidine (CAS 50-89-5) market is segmented on the basis of:
Types
Pharmaceutical Grade, Industrial Grade
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medicine, Chemical Products, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stereo Drugs
- Zhejiang NHU
- Hangzhou Neway Chemicals
- Coben Pharmaceutical
- Anhui Jintaiyang Pharmaceutical
- Wuhan Fortuna Chemical
 Market Overview.svg)
Highlights of The ?-Thymidine (CAS 50-89-5) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceutical Grade
- Industrial Grade
- By Application:
- Medicine
- Chemical Products
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the ?-Thymidine (CAS 50-89-5) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thymidine is a nucleotide that is used in DNA synthesis.
Some of the key players operating in the ?-thymidine (cas 50-89-5) market are Stereo Drugs, Zhejiang NHU, Hangzhou Neway Chemicals, Coben Pharmaceutical, Anhui Jintaiyang Pharmaceutical, Wuhan Fortuna Chemical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. ?-Thymidine (CAS 50-89-5) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. ?-Thymidine (CAS 50-89-5) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. ?-Thymidine (CAS 50-89-5) Market - Supply Chain
4.5. Global ?-Thymidine (CAS 50-89-5) Market Forecast
4.5.1. ?-Thymidine (CAS 50-89-5) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. ?-Thymidine (CAS 50-89-5) Market Size (000 Units) and Y-o-Y Growth
4.5.3. ?-Thymidine (CAS 50-89-5) Market Absolute $ Opportunity
5. Global ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Type
5.3.1. Pharmaceutical Grade
5.3.2. Industrial Grade
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Application
6.3.1. Medicine
6.3.2. Chemical Products
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global ?-Thymidine (CAS 50-89-5) Demand Share Forecast, 2019-2026
9. North America ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Application
9.4.1. Medicine
9.4.2. Chemical Products
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Type
9.7.1. Pharmaceutical Grade
9.7.2. Industrial Grade
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America ?-Thymidine (CAS 50-89-5) Demand Share Forecast, 2019-2026
10. Latin America ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Application
10.4.1. Medicine
10.4.2. Chemical Products
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Type
10.7.1. Pharmaceutical Grade
10.7.2. Industrial Grade
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America ?-Thymidine (CAS 50-89-5) Demand Share Forecast, 2019-2026
11. Europe ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Application
11.4.1. Medicine
11.4.2. Chemical Products
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Type
11.7.1. Pharmaceutical Grade
11.7.2. Industrial Grade
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projctions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe ?-Thymidine (CAS 50-89-5) Demand Share, 2019-2026
12. Asia Pacific ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Application
12.4.1. Medicine
12.4.2. Chemical Products
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Type
12.7.1. Pharmaceutical Grade
12.7.2. Industrial Grade
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific ?-Thymidine (CAS 50-89-5) Demand Share, 2019-2026
13. Middle East & Africa ?-Thymidine (CAS 50-89-5) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Application
13.4.1. Medicine
13.4.2. Chemical Products
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa ?-Thymidine (CAS 50-89-5) Market Size and Volume Forecast by Type
13.7.1. Pharmaceutical Grade
13.7.2. Industrial Grade
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa ?-Thymidine (CAS 50-89-5) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global ?-Thymidine (CAS 50-89-5) Market: Market Share Analysis
14.2. ?-Thymidine (CAS 50-89-5) Distributors and Customers
14.3. ?-Thymidine (CAS 50-89-5) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stereo Drugs
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zhejiang NHU
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hangzhou Neway Chemicals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Coben Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Anhui Jintaiyang Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Wuhan Fortuna Chemical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
